Literature DB >> 22426547

Structure of the activating IL-1 receptor signaling complex.

Christoph Thomas1, J Fernando Bazan, K Christopher Garcia.   

Abstract

Interleukin-1 (IL-1)-family cytokines are mediators of innate and adaptive immunity. They exert proinflammatory effects by binding a primary receptor that recruits a receptor accessory protein to form a signaling-competent heterotrimeric complex. Here we present the crystal structure of IL-1β bound to its primary receptor IL-1RI and its receptor accessory protein IL-1RAcP, providing insight into how IL-1-type cytokines initiate signaling and revealing an evolutionary relationship with the fibroblast growth factor receptor family.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22426547      PMCID: PMC4006550          DOI: 10.1038/nsmb.2260

Source DB:  PubMed          Journal:  Nat Struct Mol Biol        ISSN: 1545-9985            Impact factor:   15.369


  20 in total

1.  Molecular characteristics of fibroblast growth factor-fibroblast growth factor receptor-heparin-like glycosaminoglycan complex.

Authors:  G Venkataraman; R Raman; V Sasisekharan; R Sasisekharan
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

2.  beta-Trefoil fold. Patterns of structure and sequence in the Kunitz inhibitors interleukins-1 beta and 1 alpha and fibroblast growth factors.

Authors:  A G Murzin; A M Lesk; C Chothia
Journal:  J Mol Biol       Date:  1992-01-20       Impact factor: 5.469

3.  Model of interaction of the IL-1 receptor accessory protein IL-1RAcP with the IL-1beta/IL-1R(I) complex.

Authors:  R Casadio; E Frigimelica; P Bossù; D Neumann; M U Martin; A Tagliabue; D Boraschi
Journal:  FEBS Lett       Date:  2001-06-15       Impact factor: 4.124

Review 4.  The interleukin-1 receptor family.

Authors:  Diana Boraschi; Aldo Tagliabue
Journal:  Vitam Horm       Date:  2006       Impact factor: 3.421

5.  Structural insights into the assembly and activation of IL-1β with its receptors.

Authors:  Dongli Wang; Senyan Zhang; Liang Li; Xi Liu; Kunrong Mei; Xinquan Wang
Journal:  Nat Immunol       Date:  2010-08-29       Impact factor: 25.606

6.  IL-1 family nomenclature.

Authors:  Charles Dinarello; William Arend; John Sims; Dirk Smith; Hal Blumberg; Luke O'Neill; Raphaela Goldbach-Mansky; Theresa Pizarro; H Hoffman; Philip Bufler; Marcel Nold; Pietro Ghezzi; Alberto Mantovani; Cecilia Garlanda; Diana Boraschi; Anna Rubartelli; Mihai Netea; Jos van der Meer; Leo Joosten; Tom Mandrup-Poulsen; Marc Donath; Eli Lewis; Josef Pfeilschifter; Michael Martin; Michael Kracht; H Muehl; Daniela Novick; Miodrag Lukic; Bruno Conti; Alan Solinger; Peyman Kelk; Kelk Peyman; Frank van de Veerdonk; Chiristopher Gabel
Journal:  Nat Immunol       Date:  2010-11       Impact factor: 25.606

7.  The crystal structure of the human toll-like receptor 10 cytoplasmic domain reveals a putative signaling dimer.

Authors:  Tomas Nyman; Pål Stenmark; Susanne Flodin; Ida Johansson; Martin Hammarström; Pär Nordlund
Journal:  J Biol Chem       Date:  2008-03-10       Impact factor: 5.157

Review 8.  IL-1, IL-18, and IL-33 families of cytokines.

Authors:  William P Arend; Gaby Palmer; Cem Gabay
Journal:  Immunol Rev       Date:  2008-06       Impact factor: 12.988

9.  Structural linkage between ligand discrimination and receptor activation by type I interferons.

Authors:  Christoph Thomas; Ignacio Moraga; Doron Levin; Peter O Krutzik; Yulia Podoplelova; Angelica Trejo; Choongho Lee; Ganit Yarden; Susan E Vleck; Jeffrey S Glenn; Garry P Nolan; Jacob Piehler; Gideon Schreiber; K Christopher Garcia
Journal:  Cell       Date:  2011-08-19       Impact factor: 41.582

10.  Structural basis of receptor sharing by interleukin 17 cytokines.

Authors:  Lauren K Ely; Suzanne Fischer; K Christopher Garcia
Journal:  Nat Immunol       Date:  2009-10-18       Impact factor: 25.606

View more
  50 in total

Review 1.  Structural insights into the assembly of large oligomeric signalosomes in the Toll-like receptor-interleukin-1 receptor superfamily.

Authors:  Ryan Ferrao; Jixi Li; Elisa Bergamin; Hao Wu
Journal:  Sci Signal       Date:  2012-05-29       Impact factor: 8.192

2.  Extending the Detection Limit in Fragment Screening of Proteins Using Reverse Micelle Encapsulation.

Authors:  Brian Fuglestad; Nicole E Kerstetter; Sabrina Bédard; A Joshua Wand
Journal:  ACS Chem Biol       Date:  2019-10-03       Impact factor: 5.100

3.  Design of a superior cytokine antagonist for topical ophthalmic use.

Authors:  Jinzhao Hou; Sharon A Townson; Joseph T Kovalchin; Allyson Masci; Olga Kiner; Yanqun Shu; Bracken M King; Emily Schirmer; Kathryn Golden; Christoph Thomas; K Christopher Garcia; Gregory Zarbis-Papastoitsis; Eric S Furfine; Thomas M Barnes
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-19       Impact factor: 11.205

4.  Specific targeting of IL-1β activity to CD8+ T cells allows for safe use as a vaccine adjuvant.

Authors:  Jan Tavernier; Sarah Gerlo; Bram Van Den Eeckhout; Lien Van Hoecke; Elianne Burg; Sandra Van Lint; Frank Peelman; Niko Kley; Gilles Uzé; Xavier Saelens
Journal:  NPJ Vaccines       Date:  2020-07-23       Impact factor: 7.344

Review 5.  Structural biology of innate immunity.

Authors:  Qian Yin; Tian-Min Fu; Jixi Li; Hao Wu
Journal:  Annu Rev Immunol       Date:  2015-01-22       Impact factor: 28.527

6.  Association of the Precursor of Interleukin-1β and Peritoneal Inflammation-Role in Pathogenesis of Endometriosis.

Authors:  Justyna Sikora; Aleksandra Mielczarek-Palacz; Zdzisława Kondera-Anasz
Journal:  J Clin Lab Anal       Date:  2016-03-28       Impact factor: 2.352

Review 7.  Structural biology of the IL-1 superfamily: key cytokines in the regulation of immune and inflammatory responses.

Authors:  Brian Krumm; Yan Xiang; Junpeng Deng
Journal:  Protein Sci       Date:  2014-03-04       Impact factor: 6.725

Review 8.  Molecular basis of NF-κB signaling.

Authors:  Johanna Napetschnig; Hao Wu
Journal:  Annu Rev Biophys       Date:  2013-03-11       Impact factor: 12.981

9.  The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1β.

Authors:  Jean-Michel Rondeau; Paul Ramage; Mauro Zurini; Hermann Gram
Journal:  MAbs       Date:  2015-08-18       Impact factor: 5.857

Review 10.  TLR agonists: our best frenemy in cancer immunotherapy.

Authors:  Sabina Kaczanowska; Ann Mary Joseph; Eduardo Davila
Journal:  J Leukoc Biol       Date:  2013-03-08       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.